Announcing the results of the 2026 INFORMS Board of Directors election and the new board for 2027.
INFORMS has named 12 distinguished leaders as the 2026 class of INFORMS Fellows, one of the highest honors in the profession.
Most medical devices do not hit the market through rigorous safety testing but by being deemed similar enough to something already approved—the “predicate” device through a mechanism known as the FDA’s 510(k) pathway. But similar is not a synonym for safe. While the assumption may be that substantial equivalence is a reasonable stand-in for a safety review, a share of devices cleared with this method still get recalled, and the FDA spends valuable time reviewing devices the same way, regardless of how risky it is on paper.
An audio journey of how data and analytics save lives, save money and solve problems.
Jeff Cohen
Chief Strategy Officer
INFORMS
Catonsville, MD
[email protected]
443-757-3565
Explore our resources for multiple topics including:
As more and more people get vaccinated, many companies are starting to think about bringing employees back. When and how are the two big questions.
Medically Necessary is a FreightWaves podcast about the health care supply chain — how we get drugs, devices and medical supplies to medical providers and patients.
There aren’t enough chips to go around. The ongoing global semiconductor shortagemeans the difficulty of buying a PlayStation 5, Xbox Series X, or high-end GPU from companies like Nvidia or AMD could go on for months — if not for the rest of 2021.
The 2020 LinkedIn U.S. Emerging Jobs Reportidentified the top 15 jobs over the previous five years and emphasized that “artificial intelligence and data science roles continue to proliferate across nearly every industry.” Artificial intelligence specialist (No. 1) showed 74% annual growth, and data scientist (No. 3) and data engineer (No. 8) followed with 37% and 33% annual growth.
Walgreens has inoculated hundreds of thousands of Americans against COVID-19 this year using the vaccine developed by Pfizer and Germany’s BioNTech. But the pharmacy chain has not been following guidance from federal health officials about the timing of second doses.
OR/MS Today is the INFORMS member magazine that shares the latest research and best practices in operations research, analytics and the management sciences.
Access OR/MS Today Magazine
Analytics magazine showcases articles and research reports based on big data, AI, machine learning, data analytics and other new-age technologies.
Access Analytics Magazine